Formulation for Tin-.sup.117m /diethylenetriaminepentaacetic acids
Patent
·
OSTI ID:872770
- Setauket, NY
- Middle Island, NY
The invention provides improved formulations of .sup.117m Sn (Sn.sup.4+) DTPA which allow higher doses of .sup.117m Sn (Sn.sup.4+) to be administered than were previously possible. Methods for making pharmaceutical compositions comprising .sup.117m Sn (Sn.sup.4+) DTPA in which the amount of unchelated DTPA is minimized are disclosed along with methods of using the improved formlulations, both for palliation of bone pain associated with cancer and for treatment of osseous tumors.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
- DOE Contract Number:
- AC02-98CH10886
- Assignee:
- Brookhaven Science Associates (Upton, NY)
- Patent Number(s):
- US 6004532
- OSTI ID:
- 872770
- Country of Publication:
- United States
- Language:
- English
Improved specific activity of reactor produced 117mSn with the Szilard-Chalmers process
|
journal | September 1992 |
Cancer therapy using bone-seeking isotopes
|
journal | October 1996 |
Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases.
|
journal | January 1993 |
Tin-117m: Production, chemistry and evaluation as a bone-scanning agent
|
journal | June 1973 |
Similar Records
Formulation for tin-{sup 117m}/diethylenetriaminepentaacetic acids
Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids
Palliation of bone pain with Sn-117m(4+)DTPA
Patent
·
Tue Dec 21 00:00:00 EST 1999
·
OSTI ID:872770
Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids
Patent
·
Wed Jan 01 00:00:00 EST 2003
·
OSTI ID:872770
Palliation of bone pain with Sn-117m(4+)DTPA
Journal Article
·
Sun May 01 00:00:00 EDT 1994
· Journal of Nuclear Medicine
·
OSTI ID:872770
Related Subjects
formulation
tin-
117m
diethylenetriaminepentaacetic
acids
provides
improved
formulations
dtpa
allow
doses
administered
previously
methods
pharmaceutical
compositions
comprising
amount
unchelated
minimized
disclosed
formlulations
palliation
bone
pain
associated
cancer
treatment
osseous
tumors
pharmaceutical compositions
bone pain
acetic acid
provides improved
compositions comprising
pharmaceutical composition
/424/999/600/
tin-
117m
diethylenetriaminepentaacetic
acids
provides
improved
formulations
dtpa
allow
doses
administered
previously
methods
pharmaceutical
compositions
comprising
amount
unchelated
minimized
disclosed
formlulations
palliation
bone
pain
associated
cancer
treatment
osseous
tumors
pharmaceutical compositions
bone pain
acetic acid
provides improved
compositions comprising
pharmaceutical composition
/424/999/600/